Tianjin MNCHIP Technologies Co.
Latest round
- Series B
Last raised
- Jul 2018
Total raised
- $2.2M
Investors
- 5
About Tianjin MNCHIP Technologies Co.
, Ltd, trading under the name MNChip, focuses on developing rapid and precise in-vitro diagnostic solutions. The company applies microfluidic technology to simplify complex biochemical testing and expand access to reliable diagnostic tools. MNChip’s product lines, Celercare and Pointcare, are now used by healthcare and veterinary institutions in over 20 countries. As of 2022, MNChip had supplied more than 20,000 devices worldwide. The company's main products include fully automatic biochemical analyzers designed for clinical and veterinary diagnostics. Its Celercare and Pointcare series are based on microfluidic technology, requiring minimal blood samples and providing rapid, comprehensive results. The company generates revenue primarily through the sale of diagnostic analyzers and related consumables to hospitals, laboratories, and veterinary clinics. The company also provides after-sales support, calibration and maintenance services to its clients. MNChip aims to broaden its international market reach and expand its product portfolio by launching new immunoassay and hematology analyzers. The company also plans to enhance its R&D capacity in microfluidic diagnostics to further support accessible and cost-effective testing solutions globally.
Who invested in Tianjin MNCHIP Technologies Co.
5 investors across 3 rounds
See all investors in Tianjin MNCHIP Technologies Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tianjin MNCHIP Technologies Co.
Who invested in Tianjin MNCHIP Technologies Co.?
Tianjin MNCHIP Technologies Co. has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tianjin MNCHIP Technologies Co. raised?
Tianjin MNCHIP Technologies Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Tianjin MNCHIP Technologies Co. last raise money?
Tianjin MNCHIP Technologies Co.'s most recent round on record is a Series B, in Jul 2018.
What does Tianjin MNCHIP Technologies Co. do?
, Ltd, trading under the name MNChip, focuses on developing rapid and precise in-vitro diagnostic solutions.
Where is Tianjin MNCHIP Technologies Co. headquartered?
Tianjin MNCHIP Technologies Co. is headquartered in Tianjin, China.
Which VCs invest in companies like Tianjin MNCHIP Technologies Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Tianjin MNCHIP Technologies Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Tianjin MNCHIP Technologies Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.